Novartis Institutes for BioMedical Research, Inc., 10% Owner at Intellia Therapeutics, Inc. (NTLA), sold 1,523,000 shares at $18.30 ($27.9M) on 2017-12-12, disclosed to the SEC on 2017-12-14.
Open-market sale of $27.9M NTLA by 10% Owner. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| Filing → |